the aid library

LIST OPTIONS

Filter

2772

Sort by:

Direction:

Download (524)

View PDF (913)

Building Local Coalitions for containing drug resistance: A guide

USAID, Strengthening Pharmaceutical Systems SPS (2011) C1

Download (326)

View PDF (649)

Living Conditions among People with Disabilities in Lesotho: A National Representative Study

SINTEF Technology and Society Global Health and Welfare (2011) C2

This research report provides results from the study of living conditions among people with disabilities in Lesotho. Comparisons are made between disabled and non-disabled in household level and individual level. Disability was defined as limitation to perform certain activities that was measure... more

Download (260)

View PDF (519)

Living Conditions among People with Activity Limitations in Malawi. A National Representative Study.

ME Loeb, Arne H Eide SINTEF Health Research (2004) C1

This research report provides results from the study on living conditions among people with disabilities in Malawi. Comparisons are made between individuals with and without disabilities and also between households with and without a disabled family member. Results obtained in Malawi are also comp... more

Download (435)

View PDF (1481)

Baseline assessment of community based TB services in 8 WHO ENGAGE-TB priority countries

World Health Organization WHO (2018) C_WHO

This document contains a series of desk reviews for the eight ENGAGE-TB priority countries supported by the Global Fund (DRC, Kenya, Indonesia, Mozambique, Myanmar, Nigeria, Pakistan and Tanzania). The document provides a situation assessment and gap analysis about the state of community based TB ac... more

Download (290)

View PDF (504)

Living Conditions among People with Activity Limitations in Zambia: A National Representative Study.

Arne H Eide & ME Loeb SINTEF Health Research (2006) C1

This research report provides results from the study on living conditions among people with disabilities in Zambia. Comparisons are made between individuals with and without disabilities and also between households with and without a disabled family member. Results obtained in Zambia are also compar... more

Download (290)

View PDF (465)

Living conditions among people with disability in Botswana

Arne H. Eide & Tlamelo Mmatli SINTEF Technology and Society Health Research (2016) C1

This is a report from a National, representative household survey carried out in Botswana in 2012 – 2014. The study was carried out on behalf of the Norwegian Federation of Organisations of Disabled Persons (FFO), Southern Africa Federation of the Disabled (SASFOD) and Botswana Federation of Disab... more

Download (385)

View PDF (558)

Report: Baseline Study for Rural and Remote Education Initiative for Papuan Provinces - Report of Findings

Myriad Research; UNICEF; Australian Government Department of Foreign Affairs and Trade (2016)

Download (335)

View PDF (472)

Myanmar Living Conditions Survey 2017: Key Indicators Report

The Republic of the Union of Myanmar, Ministry of Planning and Finance, Central Statistical Organization et al. (2018) C1

The survey is representative of the Union Territory, its states and regions and urban and rural areas. It was conducted in all the districts and in 296 of the 330 townships of Myanmar. A total of 13,730 households were interviewed. It collects data on the occupations of people, how much income they ... more

Download (143)

View PDF (251)

Durable Peace Programme: Baseline Report (Myanmar)

Durable Peace Programme Consortium (2016) C1

This baseline survey and report examine the Durable Peace Programme (DPP) in Myanmar, which delivers a broad range of activities. The report provides an insight into the current situation facing both internally displaced persons (IDPs) and conflict-affected non-IDP communities in Kachin state, Myanm... more

Download (289)

View PDF (406)

Myannmar Living Conditions Survey 2017: Key Indicators Report

Central Statistical Organization (CSO), UNDP and WB (2018) C1

Download (172)

View PDF (262)

Baseline and End-Line Studies as Means to Analyze the Effectiveness of Community-Based Disaster Risk Reduction Activities

Myanmar Red Cross Society (2012) C1

CBDRR Practice. Case Studies 3
No publication year indicated.

Download (109)

View PDF (142)

Répondre à la COVID-19 en Afrique: Utiliser les Données pour Trouver un Équilibre

WHO; Africa CDC; World Economic Forum et al. PERC (2020) C_WHO

Dans ce rapport, le Partnership for Evidence-Based Response to COVID-19 (PERC), un consortium d’organisations mondiales de santé publique et d’entreprises privées, fait la synthèse des résultats d’une enquête conduite du 29 mars au 17 avril 2020 dans 28 villes des États Membres de l’UA... more

Download (149)

View PDF (200)

Baseline Study Report Female Genital Mutilation/Cutting and Child Marriage among the Rendille, Maasai, Pokot, Samburu and Somali Communities in Kenya

United Nations Children’s Fund (UNICEF) (2017) C_UNICEF

In recognition that Female Genital Mutilation (FGM) is not only a harmful practice but a violation of human rights, Kenya has adopted a robust legal framework. The country has ratified several international legal instruments that have become part of the Kenyan law as provided for in Article 2 of the... more

Download (106)

View PDF (156)

Paediatric Oncology Nursing Care in low- and middle-income countries: a need for baseline standards

Day S., Challinor J., Hollis R., et al. (2015) CC

This article looks at the Baseline Standards developed by the International Society for Paediatric Oncology (SIOP) for paediatric oncology nursing care in low- and middle-income countries. The Baseline Standards lay the foundation for effective care and address barriers such as inadequate staffin... more

Download (112)

View PDF (117)

Assessing health systems in Guinea for prevention and control of priority zoonotic diseases: A One Health approach

Standleya C. J., Carlinb E. P., Sorrella E. M. et al. Elsevier (2019) CC

To guide One Health capacity building efforts in the Republic of Guinea in the wake of the 2014–2016 Ebola virus disease (EVD) outbreak, we sought to identify and assess the existing systems and structures for zoonotic disease detection and control. We partnered with the government ministries resp... more

Download (101)

View PDF (174)

Considering climate and conflict conditions together to improve interventions that prevent child acute malnutrition

Brown, M.E.; Grace, K.; Billing T.; et al. (2021) C1

Lancet Planet Health 2021; 5: e654–58

Download (90)

View PDF (661)

Modelling the effects of global climate change on Chikungunya transmission in the 21st century

Tjaden, N.B.; J.E. Suk, D. Fischer et al. Nature Scientific Reports (2017) CC

The arrival and rapid spread of the mosquito-borne viral disease Chikungunya across the Americas is one of the most significant public health developments of recent years, preceding and mirroring the subsequent spread of Zika. Globalization in trade and travel can lead to the importation of these vi... more

Download (176)

View PDF (172)

Health Inequalities in Latin America and the Caribbean. A Baseline for the Global Strategy for Women’s, Children’s and Adolescents’ Health

Pan American Health Organization (PAHO) (2023) C_WHO

his publication provides an overview of social inequalities in several indicators related to the health of women, children, and adolescents in a region deemed as one with high levels of inequality: Latin America and the Caribbean (LAC). In order for it to serve as a baseline for the 2030 Agenda, emp... more

Download (76)

View PDF (103)

Validated baselines for the Mental health action plan for the WHO South-East Asia Region2023–2030

World Health Organisation (WHO) (2023) C_WHO

Member States of the Region have initiated processes to strengthen leadership and governance for mental health. Several countries have developed and implemented mental health plans, strategies and legislations. Direct spending on mental health needs to be increased throughout the Region through the ... more

Download (244)

View PDF (328)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more